BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33768628)

  • 1. Drug-related problems of antipsychotics in treating delirium among elderly patients: A real-world observational study.
    Jenraumjit R; Somboon J; Chainan S; Chuenchom P; Wongpakaran N; Wongpakaran T
    J Clin Pharm Ther; 2021 Oct; 46(5):1274-1280. PubMed ID: 33768628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for the treatment of delirious elders.
    Ozbolt LB; Paniagua MA; Kaiser RM
    J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
    Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F
    Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of antipsychotics in treating delirium.
    Tune L
    Curr Psychiatry Rep; 2002 Jun; 4(3):209-12. PubMed ID: 12003684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotics for delirium in the general hospital setting in consecutive 2453 inpatients: a prospective observational study.
    Hatta K; Kishi Y; Wada K; Odawara T; Takeuchi T; Shiganami T; Tsuchida K; Oshima Y; Uchimura N; Akaho R; Watanabe A; Taira T; Nishimura K; Hashimoto N; Usui C; Nakamura H
    Int J Geriatr Psychiatry; 2014 Mar; 29(3):253-62. PubMed ID: 23801358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Antipsychotic Safety in the CICU.
    Hanna MP; Adie SK; Ketcham SW; Deshmukh A; Gondi K; Abdul-Aziz AA; Prescott HC; Thomas MP; Konerman MC
    Am J Cardiol; 2022 Jan; 163():117-123. PubMed ID: 34794647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
    Briskman I; Dubinski R; Barak Y
    Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.
    Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ
    Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial.
    Stollings JL; Boncyk CS; Birdrow CI; Chen W; Raman R; Gupta DK; Roden DM; Rivera EL; Maiga AW; Rakhit S; Pandharipande PP; Ely EW; Girard TD; Patel MB
    JAMA Netw Open; 2024 Jan; 7(1):e2352034. PubMed ID: 38252439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotics can induce pre-shock in very elderly patients: a report of two cases.
    Ueda S; Omori A; Shioya T; Okubo Y
    Psychogeriatrics; 2016 Jan; 16(1):73-5. PubMed ID: 25914062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
    Lawrence KR; Nasraway SA
    Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients.
    Rea RS; Battistone S; Fong JJ; Devlin JW
    Pharmacotherapy; 2007 Apr; 27(4):588-94. PubMed ID: 17381385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perceptions and practices surrounding the recognition and treatment of delirium in the intensive care unit: a survey of 250 critical care pharmacists from eight states.
    Devlin JW; Bhat S; Roberts RJ; Skrobik Y
    Ann Pharmacother; 2011 Oct; 45(10):1217-29. PubMed ID: 21934036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
    Boettger S; Knöpfel S; Schubert M; Garcia Nuñez D; Plichta MM; Klaghofer R; Jenewein J
    Swiss Med Wkly; 2017; 147():w14471. PubMed ID: 28750419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for delirium in terminally ill adults.
    Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.